Pui-Kai Li, PhD
College of Pharmacy
Molecular Carcinogenesis and Chemoprevention
Cancer ● Breast Cancer ● Prostatic Cancer ● Glioblastoma ● Osteosarcoma ● Amnesia
Pui-Kai Li, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where he brings a pharmacological perspective.His research explores the design, synthesis and biochemical testing of sulfatase inhibitors as possible agents in treatment of hormone-dependent cancers. One of his recent studies indicates that enhancing protein kinase C beta II (PKCßII) activity may be a therapeutic strategy to mitigate cancer-mediated suppression of the immune system. Dr. Li has co-authored many articles in well-respected publications, including International Journal of Gynecological Cancer, Bioorganic & Medicinal Chemistry Letters, Cancer Research and International Journal of Cancer.